Evidence map›Paper›PMID 31557840›Full record

ArticleBiomolecules2019

Two Auxin Response Elements Fine-Tune

André Kuhn, Bethany Runciman, William Tasker-Brown, Lars Østergaard

Abstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. International journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Auxin and Flower Development: A Blossoming Field.Cold Spring Harbor perspectives in biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

André KuhnDepartment of Crop Genetics, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK. andre.kuhn@jic.ac.uk.ORCID 0000-0003-2144-8413
Bethany RuncimanDepartment of Crop Genetics, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK. b.runciman@aol.co.uk.
William Tasker-BrownDepartment of Crop Genetics, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK. billy.tasker-brown@jic.ac.uk.ORCID 0000-0002-7427-0842
Lars ØstergaardDepartment of Crop Genetics, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK. lars.ostergaard@jic.ac.uk.ORCID 0000-0002-8497-7657

Funding

Biotechnology and Biological Sciences Research Council BB/I017232/1Biotechnology and Biological Sciences Research Council BB/M011216/1Biotechnology and Biological Sciences Research Council BB/P013511/1
6 · The paper itself

Abstract

The plant hormone auxin controls almost all aspects of plant development through the gene regulatory properties of auxin response factors (ARFs) which bind so-called auxin responsive elements (AuxREs) in regulatory regions of their target genes. It has been proposed that ARFs interact and cooperate with other transcription factors (TFs) to bind to complex DNA-binding sites harboring cis-elements for several TFs. Complex DNA-binding sites have not been studied systematically for ARF target genes. ETTIN (ETT; ARF3) is a key regulator of gynoecium development. Cooperatively with its interacting partner INDEHISCENT (IND), ETT regulates

Indexed as

ArabidopsisArabidopsis ProteinsDrosophila ProteinsFlowersGene Expression ProfilingGene Expression Regulation, PlantHomeodomain ProteinsIndoleacetic AcidsMutationPromoter Regions, GeneticProtein Serine-Threonine KinasesResponse ElementsArabidopsis ProteinsDrosophila ProteinsHomeodomain ProteinsIndoleacetic AcidsIND protein, DrosophilaPINOID protein, ArabidopsisProtein Serine-Threonine Kinasesauxin responsecis-regulationETTINgene regulationgynoeciumINDEHISCENTPINOIDplant development

Identifiers

PMID31557840
PMCPMC6843594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.